306 related articles for article (PubMed ID: 11075354)
1. Phage display for selection of novel binding peptides.
Sidhu SS; Lowman HB; Cunningham BC; Wells JA
Methods Enzymol; 2000; 328():333-63. PubMed ID: 11075354
[No Abstract] [Full Text] [Related]
2. Selectively infective phage technology.
Arndt KM; Jung S; Krebber C; Plückthun A
Methods Enzymol; 2000; 328():364-88. PubMed ID: 11075355
[No Abstract] [Full Text] [Related]
3. Solution structure of a phage-derived peptide antagonist in complex with vascular endothelial growth factor.
Pan B; Li B; Russell SJ; Tom JY; Cochran AG; Fairbrother WJ
J Mol Biol; 2002 Feb; 316(3):769-87. PubMed ID: 11866530
[TBL] [Abstract][Full Text] [Related]
4. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site.
Fairbrother WJ; Christinger HW; Cochran AG; Fuh G; Keenan CJ; Quan C; Shriver SK; Tom JY; Wells JA; Cunningham BC
Biochemistry; 1998 Dec; 37(51):17754-64. PubMed ID: 9922141
[TBL] [Abstract][Full Text] [Related]
5. Crystal structure of the complex between VEGF and a receptor-blocking peptide.
Wiesmann C; Christinger HW; Cochran AG; Cunningham BC; Fairbrother WJ; Keenan CJ; Meng G; de Vos AM
Biochemistry; 1998 Dec; 37(51):17765-72. PubMed ID: 9922142
[TBL] [Abstract][Full Text] [Related]
6. Efficient phage display of polypeptides fused to the carboxy-terminus of the M13 gene-3 minor coat protein.
Fuh G; Sidhu SS
FEBS Lett; 2000 Sep; 480(2-3):231-4. PubMed ID: 11034335
[TBL] [Abstract][Full Text] [Related]
7. Homodimeric peptides displayed by the major coat protein of filamentous phage.
Zwick MB; Shen J; Scott JK
J Mol Biol; 2000 Jul; 300(2):307-20. PubMed ID: 10873467
[TBL] [Abstract][Full Text] [Related]
8. Disulfide structure of the heparin binding domain in vascular endothelial growth factor: characterization of posttranslational modifications in VEGF.
Keck RG; Berleau L; Harris R; Keyt BA
Arch Biochem Biophys; 1997 Aug; 344(1):103-13. PubMed ID: 9244387
[TBL] [Abstract][Full Text] [Related]
9. Solution structure of the heparin-binding domain of vascular endothelial growth factor.
Fairbrother WJ; Champe MA; Christinger HW; Keyt BA; Starovasnik MA
Structure; 1998 May; 6(5):637-48. PubMed ID: 9634701
[TBL] [Abstract][Full Text] [Related]
10. Selection and application of peptide-binding peptides.
Zhang Z; Zhu W; Kodadek T
Nat Biotechnol; 2000 Jan; 18(1):71-4. PubMed ID: 10625395
[TBL] [Abstract][Full Text] [Related]
11. Design and expression of soluble CTLA-4 variable domain as a scaffold for the display of functional polypeptides.
Nuttall SD; Rousch MJ; Irving RA; Hufton SE; Hoogenboom HR; Hudson PJ
Proteins; 1999 Aug; 36(2):217-27. PubMed ID: 10398368
[TBL] [Abstract][Full Text] [Related]
12. Selection of phage-display peptides that bind to cucumber mosaic virus coat protein.
Gough KC; Cockburn W; Whitelam GC
J Virol Methods; 1999 May; 79(2):169-80. PubMed ID: 10381087
[TBL] [Abstract][Full Text] [Related]
13. Size of the ligand complex between the N-terminal domain of the gene III coat protein and the non-infectious phage strongly influences the usefulness of in vitro selective infective phage technology.
Cèbe R; Geiser M
Biochem J; 2000 Dec; 352 Pt 3(Pt 3):841-9. PubMed ID: 11104694
[TBL] [Abstract][Full Text] [Related]
14. Biopanning and rapid analysis of selective interactive ligands.
Giordano RJ; Cardó-Vila M; Lahdenranta J; Pasqualini R; Arap W
Nat Med; 2001 Nov; 7(11):1249-53. PubMed ID: 11689892
[TBL] [Abstract][Full Text] [Related]
15. Engineering nucleic acid-binding proteins by phage display.
Isalan M; Choo Y
Methods Mol Biol; 2001; 148():417-29. PubMed ID: 11357603
[No Abstract] [Full Text] [Related]
16. Inhibition of vascular endothelial growth factor-induced receptor activation with anti-kinase insert domain-containing receptor single-chain antibodies from a phage display library.
Zhu Z; Rockwell P; Lu D; Kotanides H; Pytowski B; Hicklin DJ; Bohlen P; Witte L
Cancer Res; 1998 Aug; 58(15):3209-14. PubMed ID: 9699643
[TBL] [Abstract][Full Text] [Related]
17. Peptabodies as tools to test ligands isolated from phage-displayed peptide libraries.
Clément G; Bisoffi M; Finger AN; Wetterwald A; Thalmann GN; Cecchini MG
J Immunol Methods; 2003 May; 276(1-2):135-41. PubMed ID: 12738366
[TBL] [Abstract][Full Text] [Related]
18. Use of fusions to viral coat proteins as antigenic carriers for vaccine development.
Stockley PG; Mastico RA
Methods Enzymol; 2000; 326():551-69. PubMed ID: 11036664
[No Abstract] [Full Text] [Related]
19. [Screening for inhibitor of vascular endothelial growth factor from random peptide library].
Wu J; Zhang H; Wang J; Yang T; Xian J; Yang C; Zheng W; Chen H; Wang Q
Zhonghua Zhong Liu Za Zhi; 2002 Nov; 24(6):540-3. PubMed ID: 12667320
[TBL] [Abstract][Full Text] [Related]
20. Identification of natural ligands for SH2 domains from a phage display cDNA library.
Cochrane D; Webster C; Masih G; McCafferty J
J Mol Biol; 2000 Mar; 297(1):89-97. PubMed ID: 10704309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
